TTK Healthcare Limited

Diversified · Diversified

NSE: TTKHLTCARE BSE: 507747
₹1023.00
▼ -10.70 (-1.04%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
52/100
Moderate
Valuation
84/100
Undervalued
Momentum
30/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,446 Cr
PE (TTM)
19.5
Industry median 18.6 (12 companies)
Price to Book
1.3
PEG (TTM)
1.1
Institutions holding %
4.05%
FII + DII, latest filed period
Piotroski Score
5
Relative return vs Nifty50, qtr %
15.6
Relative return vs Sector, qtr %
25.9
Free Cash Flow
₹-27 Cr
as of March 31, 2026
Industry median ₹-0 Cr (14 companies)
EPS Growth (YoY)
63.70%
as of June 30, 2026
Industry median 32.43% (13 companies)
Net Profit Growth (TTM)
-8.71%
as of June 30, 2026
Industry median 21.47% (13 companies)
Operating Revenue Growth (TTM)
8.34%
as of June 30, 2026
Industry median 9.15% (13 companies)
Profit Growth (YoY)
18.52%
as of Sept. 30, 2025
Industry median 30.13% (13 companies)
Revenue Growth (YoY)
13.75%
as of June 30, 2026
Industry median 9.57% (12 companies)
Current Ratio
5.91
as of March 31, 2026
Industry median 3.24 (14 companies)
Debt to Equity
0.02
as of March 31, 2026
Industry median 0.26 (13 companies)
Interest Coverage
35.85
as of June 30, 2026
Industry median 10.88 (13 companies)
Net Margin
8.26%
as of June 30, 2026
Industry median 8.26% (13 companies)
Operating Margin (EBIT)
11.41%
as of June 30, 2026
Industry median 17.53% (13 companies)
Operating Margin (TTM)
10.86%
as of June 30, 2026
Industry median 12.72% (13 companies)
Return on Assets
5.30%
as of March 31, 2026
Industry median 5.35% (13 companies)
Return on Capital Employed
7.62%
as of March 31, 2026
Industry median 11.22% (13 companies)
Return on Equity
6.32%
as of March 31, 2026
Industry median 10.40% (13 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 7 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 5)
  • Yes Debt to equity is below 0.5 (0.02)
  • No Return on equity is 15% or more (6.3%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

4 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.0%
Low 1012.6000 · High 1050.6000
1W return
-2.7%
Low 1000.0000 · High 1066.8000
1M return
-11.8%
Low 1000.0000 · High 1247.0000
52W return
-11.7%
Low 735.0000 · High 1247.0000
Lifetime High ₹1843.1000 (Sept. 9, 2024)
Lifetime Low ₹287.8000 (March 23, 2020)

Full price history and technicals →

EMA & SMA

Bullish1
Bearish5
5D
1031.2
10D
1045.3
20D
1064.3
50D
1059.1
100D
1025.3
200D
965.7

Delivery and volume

Day avg. delivery
57.5%
Week avg. delivery
57.5%
Month avg. delivery
51.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1028.73
Pivot
First resistance1044.87
Second resistance1066.73
Third resistance1082.87
First support1006.87
Second support990.73
Third support968.87
Day RSI40.7
Day MFI24.1
Day MACD-18.03
Day MACD signal-9.04

Beta

1M0.04
3M0.65
1Y0.68
3Y0.61

Price change analysis

↓ -11.8%
Over 1 Month
LowHigh
1000.001247.00
↑ 12.7%
Over 3 Months
LowHigh
880.601247.00
↑ 30.6%
Over 6 Months
LowHigh
756.051247.00
↓ -11.7%
Over 1 Year
LowHigh
735.001247.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 19.5 (own history: 15.9–33.2)
Buy Zone
Revenue (June 30, 2026)
₹258 Cr
Net profit (June 30, 2026)
₹21 Cr
Basic EPS (June 30, 2026)
₹15.0600

Ranks #6 of 14 in Diversified by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter74.56%
  • FII/FPI1.86%
  • Other DII2.19%
  • Public21.39%

Largest holders

NameCategoryShares %Shares
T T Krishnamachari & Co. represented by its Partners -Mr T.T. Jagannathan and Mr T.T. RaghunnathanPromoter67.4600%9532610
ABAKKUS DIVERSIFIED ALPHA FUNDPublic2.0700%293030
MUKUND THIRUVALLUR THATTAIPromoter1.8900%267195
TIRUVALLUR THATAI LAKSHMANPromoter1.8900%267195
SARAYU THIRUVALLUR THATTAI (Duly represented by Ms. Maitri Gopalakrishna, her Mother and Natural Guardian)Promoter1.8900%267100

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 74.56% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 1.90% to 1.86% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 14 insider trades, 9 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
30 Dec 2025 Thiruvallur Thatai Lakshman Promoter group Buy 0 ₹0
30 Dec 2025 Late Thiruvallur Thattai Jagannathan Promoter Sell 0 ₹0
30 Dec 2025 Late Thiruvallur Thattai Venkatesh Promoter group Sell 0 ₹0
30 Dec 2025 Mukund Thiruvallur Thattai Promoter group Buy 0 ₹0
25 Jul 2018 VIDHIT TULSHAN Immediate relative Buy 0 ₹0
30 May 2018 SARALA TULSHAN Immediate relative Sell 0 ₹0
30 May 2018 SARALA TULSHAN Immediate relative Sell 0 ₹0
2 May 2018 R K TULSHAN Director Buy 0 ₹0
2 May 2018 R K TULSHAN Director Buy 0 ₹0
5 Mar 2018 M/s T T Krishnamachari & Co. represented by its Partners - Mr T T Jagannathan, Mr T T Raghunathan, Dr (Mrs) Latha Jagannathan and Mrs Bhanu Raghunathan Promoter Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
17 Mar 2025 UNO METALS LTD Bulk Sell 76,500 1124.2400 NSE
24 Mar 2023 MCAP INDIA FUND LIMITED Block Sell 115,385 910.0000 BSE
24 Mar 2023 ABAKKUS DIVERSIFIED ALPHA FUND Block Buy 115,385 910.0000 BSE
24 Mar 2023 ABAKKUS ASSET MANAGER LLP Block Buy 130,488 910.0000 BSE
24 Mar 2023 ABAKKUS DIVERSIFIED ALPHA FUND Bulk Buy 115,385 910.0000 BSE
24 Mar 2023 ABAKKUS ASSET MANAGER LLP Bulk Buy 131,788 911.0800 BSE
24 Mar 2023 MCAP INDIA FUND LIMITED Bulk Sell 245,873 910.0000 BSE
2 Feb 2018 THE ROYAL BANK OF SCOTLAND PLC AS TRUSTEE OF JUPITER INDIA Bulk Buy 46,696 812.4000 NSE
2 Feb 2018 JUPITER SOUTH ASIA INVESTMENT COMPANY LTD Bulk Sell 46,696 812.4000 NSE
18 Jan 2017 AXIS MF LONG TERM EQUITY FUND Bulk Sell 324,803 885.0000 NSE

All bulk and block deals →

Last 12 months ₹10.00 per share
Dividend yield 0.98%
Ex-dateSubjectPer share (₹)Record date
17 Jul 2026 Dividend - Rs 10 Per Share 10.0000 17 Jul 2026
18 Jul 2025 Annual General Meeting/Dividend - Rs 10 Per Share 10.0000 18 Jul 2025
16 Jul 2024 Annual General Meeting/Dividend - Rs10 Per Sh/ 10.0000 —
18 Jul 2023 Annual General Meeting/Dividend - Rs 10 Per Share 10.0000 —
26 Jul 2022 Annual General Meeting/Dividend - Rs 10 Per Share 10.0000 —
12 Aug 2021 Annual General Meeting/Dividend - Rs 6 Per Share 6.0000 —
3 Sep 2020 Annual General Meeting/Dividend - Rs 3 Per Share 3.0000 —
1 Aug 2019 Annual General Meeting/Dividend - Rs 5 Per Share 5.0000 —
2 Aug 2018 Annual General Meeting/Dividend- Rs 5 Per Share 5.0000 —
27 Jul 2017 Annual General Meeting/Dividend - Rs 5 Per Share 5.0000 —

Corporate Actions

Full history (19 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from TTK Pharma Ltd. to TTK Healthcare Ltd.
3 Aug 2012OTHERAnnual General Meeting/ Div. Of Rs. 4/- Per Share

All corporate actions →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
6 Aug 2026 Financial Results/Other business matters Yes
30 May 2026 Financial Results/Dividend Yes
22 Jan 2026 Financial Results/Other business matters Yes
17 Oct 2025 Financial Results/Other business matters Yes
4 Aug 2025 Financial Results Yes

Corporate Announcements

All 735 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.02)
  • Comfortable interest coverage (35.9x)

Weaknesses

  • Low Return on Equity (6.3%)

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about TTK Healthcare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.